United States Uterine Fibroids Treatment Device Market was valued at USD 0.85 Billion in 2022 and is projected to reach USD 1.80 Billion by 2030, growing at a CAGR of 9.9% from 2024 to 2030.
The US uterine fibroids treatment device market has witnessed significant growth over the past few years due to increasing awareness and advancements in medical technology. Uterine fibroids, which are benign tumors of the uterus, affect a significant portion of women, particularly those in their reproductive years. The demand for effective treatments has driven the development of innovative devices aimed at managing and alleviating symptoms associated with fibroids. The market for these devices is categorized by several treatment methods, including minimally invasive procedures and advanced surgical techniques.
One of the most prominent types of uterine fibroids treatment devices is the MRI-guided focused ultrasound (MRgFUS). This non-invasive technique uses focused ultrasound waves to target fibroid tissues, effectively shrinking them without the need for traditional surgery. This device has gained popularity due to its minimal recovery time and lack of incisions, offering a compelling alternative to more invasive procedures like myomectomy and hysterectomy. Additionally, the market also includes devices used in procedures such as uterine artery embolization, which blocks the blood supply to fibroids, causing them to shrink and die.
The rising demand for these uterine fibroids treatment devices is not only driven by medical necessity but also by the growing awareness of fibroid-related health issues. Women are increasingly seeking options that allow them to maintain fertility and avoid invasive surgery. In response to this, companies are focusing on creating devices that are user-friendly, effective, and come with minimal side effects. As healthcare industries continue to embrace non-invasive treatments, there has been a marked shift toward technologies that provide quicker recovery times, fewer complications, and more personalized care.
The uterine fibroids treatment device market is expected to grow further as more medical professionals and healthcare institutions adopt these advanced technologies. The shift toward personalized, minimally invasive procedures is shaping the future of the market, as patient preference for non-surgical treatments grows. Moreover, with increasing healthcare expenditure and greater awareness campaigns about fibroids, the demand for innovative treatment devices is poised to continue its upward trajectory.
Get an In-Depth Research Analysis of the US Uterine Fibroids Treatment Device Market Size And Forecast [2025-2032]
Â
Blue Endo
Boston Scientific Corporation
Cooper Surgical
Acessa Health
Inc.
Karl Storz
LiNA Medical
Merit Medical Systems
Olympus Corporation
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Uterine Fibroids Treatment Device Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Uterine Fibroids Treatment Device Market
Uterine Artery Embolization Devices
Laparoscopic Myomectomy Devices
Hysteroscopic Myomectomy Devices
Radiofrequency Ablation Devices
Magnetic Resonance Imaging-Guided Focused Ultrasound (MRgFUS) Devices
Laser Technology
Electrical Technology
Thermal Technology
Cryotechnology
Ultrasound Technology
Minimally Invasive Procedures
Open Surgery Procedures
Outpatient Procedures
Cumbersome Procedures
Non-surgical Procedures
Hospitals
Ambulatory Surgical Centers
Specialized Clinics
Research and Academic Institutions
Home Care Settings
Treatment of Pain and Symptoms Associated with Uterine Fibroids
Reduction of Fibroid Size
Fertility Preservation
Management of Bleeding Disorders
Improvement of Quality of Life
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Uterine Fibroids Treatment Device Market Research Analysis
1. Introduction of the US Uterine Fibroids Treatment Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Uterine Fibroids Treatment Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Uterine Fibroids Treatment Device Market, By Type
6. US Uterine Fibroids Treatment Device Market, By Application
7. US Uterine Fibroids Treatment Device Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Uterine Fibroids Treatment Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/